Jaguar Health Inc (NAS:JAGX)
$ 1.04 0 (0%) Market Cap: 9.61 Mil Enterprise Value: 27.72 Mil PE Ratio: 0 PB Ratio: 0.48 GF Score: 35/100

Jaguar Health Inc at Ladenburg Thalmann R&D Webinar Transcript

Sep 29, 2021 / 05:00PM GMT
Release Date Price: $9630 (-4.46%)
Destiny Alexandra Hance Buch
Ladenburg Thalmann & Co. Inc., Research Division - Analyst

Hello, and welcome to Ladenburg Thalmann R&D Showcase. Our showcase is designed to highlight company products in the clinical or regulatory process. Today, we are excited to highlight Jaguar Health, and we'll turn it over to management in a moment.

We would first like to bring your attention to our necessary disclosures. Further, we would like to reiterate this webinar is being recorded, and intended for the investment community. We'd also like to note the risks associated with owning shares of Jaguar Health. If you have any questions or concerns, please contact me, Destiny Hance at [email protected].

Without further ado, I will turn it over to Jeffrey Cohen, Managing Director, Equity Research. Jeff?

Jeffrey Scott Cohen
Ladenburg Thalmann & Co. Inc., Research Division - MD of Equity Research

Thank you, Destiny, and thank you, everyone for joining us. Today, we're going to be speaking with both Lisa Conte, CEO of Jaguar Health; as well as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot